Thanks, mapman, appreciate the post. I read this article also and thought the same as you about Missling’s input...all those meetings ago in DC.
Great minds...?
This appears to indicate that the FDA is aware of the problems/shortcomings of the past and the opportunities for advancement in its sphere in the future and is ready to implement and take its place among the front runners of cutting edge drug approval using the potent technology available.
Right again. The FDA knew they had a process that was broken badly, expensive, time consuming and ineffective. They admitted that today. Dr.M. signed us up in other countries, somehow got at least 2 new patents, connected w/an AI cloud based suite and developed an AD-AI biomarker template while we have ad/RS and PDD trials either underway or close. No basic contradictions to science claims that we know of. Surprising in a way how far behind BP seems to be.
No pump only stating facts as I see them. I am now looking for significant Pub on AD patent/AI biomarker effort with links back to the next trial. Strong PDD trial effort underway w/criteria that makes sense. No one knows how close we are to good news but it can't be far off. When BP gets a look at what we are doing we will have lots of friends, IMO.